HK1051190A1 - Process for the preparation of 2-(4-alkyl-1-piperazinyl-benzaldehyde and -benzylidenyl compounds. - Google Patents
Process for the preparation of 2-(4-alkyl-1-piperazinyl-benzaldehyde and -benzylidenyl compounds.Info
- Publication number
- HK1051190A1 HK1051190A1 HK03103338A HK03103338A HK1051190A1 HK 1051190 A1 HK1051190 A1 HK 1051190A1 HK 03103338 A HK03103338 A HK 03103338A HK 03103338 A HK03103338 A HK 03103338A HK 1051190 A1 HK1051190 A1 HK 1051190A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- benzylidenyl
- benzaldehyde
- piperazinyl
- alkyl
- compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
- C07D241/04—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/10—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by doubly bound oxygen or sulphur atoms
- C07D295/112—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by doubly bound oxygen or sulphur atoms with the ring nitrogen atoms and the doubly bound oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D279/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
- C07D279/10—1,4-Thiazines; Hydrogenated 1,4-thiazines
- C07D279/12—1,4-Thiazines; Hydrogenated 1,4-thiazines not condensed with other rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Heart & Thoracic Surgery (AREA)
- Pain & Pain Management (AREA)
- Cardiology (AREA)
- Addiction (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US31601001P | 2001-08-30 | 2001-08-30 |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1051190A1 true HK1051190A1 (en) | 2003-07-25 |
Family
ID=23227067
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK03103338A HK1051190A1 (en) | 2001-08-30 | 2003-05-13 | Process for the preparation of 2-(4-alkyl-1-piperazinyl-benzaldehyde and -benzylidenyl compounds. |
Country Status (24)
Country | Link |
---|---|
US (1) | US6608195B2 (zh) |
EP (1) | EP1288208B1 (zh) |
JP (1) | JP3902751B2 (zh) |
KR (1) | KR100503518B1 (zh) |
CN (1) | CN1172920C (zh) |
AR (1) | AR036373A1 (zh) |
AT (1) | ATE332897T1 (zh) |
AU (1) | AU2002300770B2 (zh) |
BR (1) | BR0203426A (zh) |
CA (1) | CA2399970A1 (zh) |
CY (1) | CY1106126T1 (zh) |
DE (1) | DE60213043T2 (zh) |
DK (1) | DK1288208T3 (zh) |
ES (1) | ES2266416T3 (zh) |
HK (1) | HK1051190A1 (zh) |
HU (1) | HUP0202907A3 (zh) |
IL (1) | IL151430A0 (zh) |
MX (1) | MXPA02008538A (zh) |
PL (1) | PL355799A1 (zh) |
PT (1) | PT1288208E (zh) |
RU (1) | RU2222533C1 (zh) |
TW (1) | TWI234563B (zh) |
YU (1) | YU62302A (zh) |
ZA (1) | ZA200206888B (zh) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050165025A1 (en) * | 2004-01-22 | 2005-07-28 | Recordati Ireland Ltd. | Combination therapy with 5HT 1A and 5HT 1B-receptor antagonists |
WO2005113526A2 (en) * | 2004-05-21 | 2005-12-01 | Pfizer Products Inc. | Metabolites of 4-(3,4-dichloro-phenyl)-2-[2-(4-methyl-piperazin-1-yl)-benzylidene]-thiomorpholin-3-one |
CN111269585B (zh) * | 2020-03-11 | 2021-10-08 | 苏州根岸生物科技有限责任公司 | 一种荧光染料及其制备方法与应用 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
UA56185C2 (uk) * | 1996-09-30 | 2003-05-15 | Пфайзер Інк. | Аралкіл- та аралкіліденгетероциклічні лактами та іміди, фармацевтична композиція та спосіб лікування |
US6248888B1 (en) * | 1997-11-14 | 2001-06-19 | Teva Pharmaceutical Industries Ltd. | Process for the preparation of terazosin hydrochloride dihydrate |
TW426667B (en) | 1997-11-19 | 2001-03-21 | Pfizer | Piperidinylaminomethyl trifluoromethyl cyclic ether compounds as substance P antagonists |
-
2002
- 2002-08-15 DK DK02255713T patent/DK1288208T3/da active
- 2002-08-15 PT PT02255713T patent/PT1288208E/pt unknown
- 2002-08-15 ES ES02255713T patent/ES2266416T3/es not_active Expired - Lifetime
- 2002-08-15 AT AT02255713T patent/ATE332897T1/de not_active IP Right Cessation
- 2002-08-15 DE DE60213043T patent/DE60213043T2/de not_active Expired - Fee Related
- 2002-08-15 EP EP02255713A patent/EP1288208B1/en not_active Expired - Lifetime
- 2002-08-21 YU YU62302A patent/YU62302A/sh unknown
- 2002-08-22 IL IL15143002A patent/IL151430A0/xx unknown
- 2002-08-26 TW TW091119264A patent/TWI234563B/zh not_active IP Right Cessation
- 2002-08-27 CN CNB021418624A patent/CN1172920C/zh not_active Expired - Fee Related
- 2002-08-27 JP JP2002246898A patent/JP3902751B2/ja not_active Expired - Fee Related
- 2002-08-28 AR ARP020103228A patent/AR036373A1/es unknown
- 2002-08-28 BR BR0203426-3A patent/BR0203426A/pt not_active IP Right Cessation
- 2002-08-28 AU AU2002300770A patent/AU2002300770B2/en not_active Ceased
- 2002-08-28 ZA ZA200206888A patent/ZA200206888B/xx unknown
- 2002-08-28 CA CA002399970A patent/CA2399970A1/en not_active Abandoned
- 2002-08-29 RU RU2002123289/04A patent/RU2222533C1/ru not_active IP Right Cessation
- 2002-08-29 MX MXPA02008538A patent/MXPA02008538A/es active IP Right Grant
- 2002-08-29 HU HU0202907A patent/HUP0202907A3/hu unknown
- 2002-08-29 KR KR10-2002-0051374A patent/KR100503518B1/ko not_active IP Right Cessation
- 2002-08-29 US US10/230,945 patent/US6608195B2/en not_active Expired - Fee Related
- 2002-08-30 PL PL02355799A patent/PL355799A1/xx not_active Application Discontinuation
-
2003
- 2003-05-13 HK HK03103338A patent/HK1051190A1/xx not_active IP Right Cessation
-
2006
- 2006-07-25 CY CY20061101030T patent/CY1106126T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
TWI234563B (en) | 2005-06-21 |
CN1172920C (zh) | 2004-10-27 |
HUP0202907A3 (en) | 2004-06-28 |
EP1288208A1 (en) | 2003-03-05 |
ES2266416T3 (es) | 2007-03-01 |
CA2399970A1 (en) | 2003-02-28 |
MXPA02008538A (es) | 2003-03-05 |
YU62302A (sh) | 2005-03-15 |
JP2003096060A (ja) | 2003-04-03 |
RU2002123289A (ru) | 2004-03-10 |
CY1106126T1 (el) | 2011-06-08 |
HU0202907D0 (zh) | 2002-10-28 |
HUP0202907A2 (hu) | 2003-06-28 |
ZA200206888B (en) | 2004-03-01 |
AU2002300770B2 (en) | 2007-06-07 |
KR100503518B1 (ko) | 2005-07-25 |
BR0203426A (pt) | 2003-05-13 |
DE60213043D1 (de) | 2006-08-24 |
DK1288208T3 (da) | 2006-10-16 |
PT1288208E (pt) | 2006-09-29 |
US20030087914A1 (en) | 2003-05-08 |
RU2222533C1 (ru) | 2004-01-27 |
IL151430A0 (en) | 2003-04-10 |
JP3902751B2 (ja) | 2007-04-11 |
DE60213043T2 (de) | 2007-01-04 |
EP1288208B1 (en) | 2006-07-12 |
US6608195B2 (en) | 2003-08-19 |
AR036373A1 (es) | 2004-09-01 |
CN1403448A (zh) | 2003-03-19 |
PL355799A1 (en) | 2003-03-10 |
ATE332897T1 (de) | 2006-08-15 |
KR20030019190A (ko) | 2003-03-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PL1651622T3 (pl) | Sposób wytwarzania związków 2-(chinoksalin-5-ylosulfonyloamino)benzamidowych | |
MXPA03010020A (es) | PROCEDIMIETO PARA LA PREPARACIoN DE UREA. | |
IL143106A (en) | Process for the preparation of diphenylmethylthioacetamide | |
MXPA03008205A (es) | Procedimiento para la preparacion de compuestos de imidazol. | |
IL161026A0 (en) | Process for the preparation of citalopram | |
HUP0401600A3 (en) | Process for the preparation of 14-hydroxymorphine derivatives | |
MXPA02006102A (es) | Metodo para preparar compuestos bormodifluoroaceticos. | |
IL159355A0 (en) | Process for the preparation of nitrile compounds | |
AU2002330042A1 (en) | Process for the preparation of 1,5-diarylpyrazoles | |
IL162188A0 (en) | Process for the preparation of Ä1,4,5Ü-oxadiazepine derivatives | |
MXPA03006606A (es) | Proceso para preparacion de analogos de indeno heterociclico. | |
HUP0303025A3 (en) | Process for the preparation of arylethanoldiamines | |
MXPA03009210A (es) | PROCEDIMIENTO PARA LA PREPARACIoN DE OXABISPIDINAS. | |
HK1051190A1 (en) | Process for the preparation of 2-(4-alkyl-1-piperazinyl-benzaldehyde and -benzylidenyl compounds. | |
AU2002329441A1 (en) | Process for the preparation of 3 - isochromanone | |
EP1295864A4 (en) | PROCESS FOR THE PREPARATION OF 1,5-DIAMINONAPHTHALINES | |
AU2002358085A1 (en) | Process for the preparation of 4-methyl-7-aminoquinolones | |
PL368905A1 (en) | Process for the preparation of beta-ionylideneacetaldehyde | |
MXPA03003068A (es) | Proceso para preparacion de tiofenoles. | |
AU2002314344A1 (en) | Process for the preparation of nitrile compounds | |
HK1046901A1 (en) | Process for the preparation of isotretinoin. | |
HUP0400095A3 (en) | Process for the preparation of citalopram | |
HUP0401165A3 (en) | Process for the preparation of 5-formylphtalide | |
GB0113667D0 (en) | Process for the preparation of endo-5-norbornene-2-ol | |
HRP20010190B1 (en) | Process for the preparation of alpha-arbutine |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20080827 |